US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

F/m Emerald Life Sciences Innovation ETF

48.06

+0.57331.21%

Post-market: 47.11-0.9528-1.98%19:30 EDT

Volume:5K

Turnover:221.35K

Market Cap:132.51M

PE:- -

High:48.19

Open:48.00

Low:47.87

Close:47.49

52wk High:48.78

52wk Low:27.34

Shares:2.76M

Float Shares:2.76M

Volume Ratio:1.31

T/O Rate:0.17%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sarepta Q2 Results Beat Expectations Despite Lower Sales Stemming from Elevidys Relabel, Unmet Roche Milestone

Nyxoah Q2 Revenue Surges on U.S. Growth, but Margins Drop

Mirum Pharmaceuticals Q2 Sales Rise, Lifts Outlook

LivaNova is Maintained at Buy by Needham

LivaNova PLC Reports Results for the Quarter Ended June 30 - Earnings Summary

Compass Pathways' Q2 Loss Widens on Commercial Readiness Activity Costs

United Therapeutics Q2 Revenue Misses Estimates on Ebulized Tyvaso Weakness

LivaNova Q2 2026 Earnings: Revenue Growth Lifts Guidance

LivaNova Q2 FY26 GAAP Diluted EPS Rises to $1.93; Revenue Increases 10.8% Year over Year to $390.6 Million

UK's LivaNova Q2 Revenue Beats Estimates; Lifts 2026 Outlook

LivaNova Says Cardiopulmonary President Stefano Folli Files Initial Beneficial Ownership Statement

LivaNova Q2 Adjusted EPS USD 1.26 Vs. IBES Estimate USD 1.1

LivaNova Q2 Adj. EPS $1.26 Beats $1.10 Estimate, Sales $390.600M Beat $380.758M Estimate

Benzinga Earnings

LivaNova: Deal Expected to Support Increased Oxygenator Output over Time, Strengthening Co Ability to Satisfy Unmet Customer Demand

THOMSON REUTERS

LivaNova Outlook FY Revenue Growth 8-9%

THOMSON REUTERS

LivaNova Outlook FY Adjusted Free Cash Flow USD 140-160 Million

THOMSON REUTERS

LivaNova - Enters Long-Term Agreement with Thermo Fisher Scientific for Oxygenator Component Supply

THOMSON REUTERS

LivaNova Plc: Announce Agreement with Thermo Fisher Scientific

THOMSON REUTERS

Press Release: LivaNova Reports Second-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance

Travere Therapeutics, Inc. : Jefferies Raises Target Price to $64 from $54

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/LFSC/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LFSC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","market":"US","secType":"STK","nameCN":"F/m Emerald Life Sciences Innovation ETF","latestPrice":48.0628,"timestamp":1787688000000,"preClose":47.4895,"halted":0,"volume":4612,"hourTrading":{"tag":"盘后","latestPrice":47.11,"preClose":48.0628,"latestTime":"19:30 EDT","volume":194,"amount":9205.2812,"timestamp":1787700602165,"change":-0.9528,"changeRate":-0.019824,"amplitude":0.019142},"delay":0,"changeRate":0.012072142263026633,"floatShares":2757035,"shares":2757035,"eps":0,"marketStatus":"Not Yet Opened","change":0.5733,"latestTime":"08-25 16:00:00 EDT","open":48,"high":48.19,"low":47.87,"amount":221346.80604,"amplitude":0.006738,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":47.4895,"sharesOutstanding":2657035,"nav":47.45,"aum":130821310.75,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":47.11,"preClose":48.0628,"latestTime":"19:30 EDT","volume":194,"amount":9205.2812,"timestamp":1787700602165,"change":-0.9528,"changeRate":-0.019824,"amplitude":0.019142},"volumeRatio":1.311494},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","floatShares":2757035,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.311494,"shares":2757035,"dividePrice":0,"high":48.19,"amplitude":0.006738,"preClose":47.4895,"low":47.87,"week52Low":27.3402,"pbRate":"--","week52High":48.78,"institutionHeld":0,"latestPrice":48.0628,"eps":0,"divideRate":0,"volume":4612,"delay":0,"ttmEps":0,"open":48,"prevYearClose":36.6147,"prevWeekClose":47.7953,"prevMonthClose":45.55,"prevQuarterClose":45.2033,"fiveDayClose":47.489,"twentyDayClose":45.3952,"sixtyDayClose":39.3901},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LFSC\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LFSC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LFSC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LFSC\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657957897","title":"Sarepta Q2 Results Beat Expectations Despite Lower Sales Stemming from Elevidys Relabel, Unmet Roche Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2657957897","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657957897?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:22","pubTimestamp":1785961340,"startTime":"0","endTime":"0","summary":"Sarepta Q2 results beat expectations despite lower sales stemming from Elevidys relabel, unmet Roche milestoneOverviewUS rare disease drugmaker's Q2 revenue fell 34% yr/yr but beat analyst expectation","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4421ER:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVTX","IE00BJJMRZ35.SGD","LFSC","IE0009355771.USD","IE00BJT1NW94.SGD","SRPT","IE00BFTCPJ56.SGD","SRPU","BK4139","BK4547","BCRX","IE00B2B36J28.USD","BK4585","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657578847","title":"Nyxoah Q2 Revenue Surges on U.S. Growth, but Margins Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2657578847","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657578847?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:16","pubTimestamp":1785961004,"startTime":"0","endTime":"0","summary":"Nyxoah Q2 revenue surges on U.S. growth, but margins dropOverviewBelgium medical device maker's Q2 revenue rose sharply yr/yr on U.S. commercializationGross margin for Q2 declined to 60% from 63% due ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4421BK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIVN","BK4551","BK4585","LU0728928796.USD","LU1084165304.USD","BK4167","LU2065171402.SGD","LU1261432733.SGD","LU2065170008.USD","BK4566","LU2065169927.USD","BK4082","PODD","INSP","BK4588","LU2324357040.USD","LU2065731478.USD","LFSC","LU2065171311.SGD","LU1119994496.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657520974","title":"Mirum Pharmaceuticals Q2 Sales Rise, Lifts Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2657520974","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657520974?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:12","pubTimestamp":1785960723,"startTime":"0","endTime":"0","summary":"Mirum Pharmaceuticals Q2 sales rise, lifts outlookOverviewRare disease drugmaker's Q2 net product sales rose 38% yr/yr to $176 mlnCompany raised 2026 net product sales guidance to $680 mln-$700 mlnQ2 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4421AC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0057025933.USD","BK4567","LU2463526074.USD","LFSC","BK4533","LU0203345920.USD","LU0289739343.SGD","LU0472753341.HKD","IE000M9KFDE8.USD","LU0069063385.USD","CMI","LU0124676726.USD","LU2065170008.USD","BK4139","ACAD","LU0689626769.HKD","MIRM","LU0511384066.AUD","LU2065169927.USD","MADE","LU0289961442.SGD","LU0154245756.USD","BK4149","BK4585","TVTX","LU0154245673.USD","BK4588","LU2065171402.SGD","LU2065171311.SGD","LU0203347892.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657521011","title":"LivaNova is Maintained at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2657521011","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657521011?lang=en_us&edition=fundamental","pubTime":"2026-08-06 01:53","pubTimestamp":1785952380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LIVN/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065169927.USD","LU2065170008.USD","BK4082","LU2065171402.SGD","LFSC","LU2065171311.SGD","LIVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657540505","title":"LivaNova PLC Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657540505","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657540505?lang=en_us&edition=fundamental","pubTime":"2026-08-05 21:32","pubTimestamp":1785936720,"startTime":"0","endTime":"0","summary":"LivaNova PLC reports results for the quarter ended June 30 - Earnings SummaryLivaNova PLCLIVN.OQreported quarterly adjusted earnings of $1.26 per share for the quarter ended June 30, higher than the s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL8N44223Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIVN","BK4082","LU2065169927.USD","LU2065171402.SGD","LU2065170008.USD","LU2065171311.SGD","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657545831","title":"Compass Pathways' Q2 Loss Widens on Commercial Readiness Activity Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2657545831","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657545831?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:45","pubTimestamp":1785926714,"startTime":"0","endTime":"0","summary":"Compass Pathways' Q2 loss widens on commercial readiness activity costsOverviewUK mental health biotech's Q2 operating income missed analyst estimatesNet loss widened yr/yr, mainly due to non-cash war","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4420FQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0757432116.USD","LFSC","BK4007","LU2089284900.SGD","LU2279689827.SGD","LU0203345920.USD","LU1880407215.USD","LU1273509221.SGD","LU0985481810.HKD","LU1718418525.SGD","FTXH","LU1585245621.USD","LU0266013472.USD","LU0306807586.USD","LU0526926950.USD","LU2539964713.USD","PSIL","LU1670710588.SGD","BMY","LU1983299246.USD","SG9999013999.USD","LU0096364046.USD","LU2596442595.SGD","LU1196032939.SGD","LU0321505868.SGD","ACAD","LU0310799852.SGD","AZN.UK","IHE","SGXZ57979304.SGD","LU0575583348.USD","LU2065171311.SGD","LU2237443978.SGD","LU2125154935.USD","LU0496365809.HKD","LU1291159041.SGD","LU1057294990.SGD","LU1989772923.USD","LIVN","SG9999001176.USD","CMPS","LU1153585028.USD","LU0997586432.USD","LU1481600234.SGD","LU1863844749.USD","LU2065170008.USD","LU0432979614.USD","LU0211326839.USD","LU1046234339.USD","03165"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657543991","title":"United Therapeutics Q2 Revenue Misses Estimates on Ebulized Tyvaso Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=2657543991","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657543991?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:38","pubTimestamp":1785926324,"startTime":"0","endTime":"0","summary":"United Therapeutics Q2 revenue misses estimates on Ebulized Tyvaso weaknessOverviewRare disease drugmaker's Q2 revenue fell 2% yr/yr, missing analyst expectationsQ2 net income rose 8% yr/yr; diluted E","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4420FK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","LFSC","BK4139","BK4532","UTHR","LU1699723380.USD","KRYS","TVTX","HELX","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657548787","title":"LivaNova Q2 2026 Earnings: Revenue Growth Lifts Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2657548787","media":"TradingKey","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657548787?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:17","pubTimestamp":1785925061,"startTime":"0","endTime":"0","summary":"LivaNova’s Q2 2026 revenue rose 10.8% to $390.6 million, while GAAP diluted EPS increased to $1.93 from $0.50 and adjusted diluted EPS reached $1.26. Cardiopulmonary and Neuromodulation each posted double-digit reported growth. The company raised constant-currency revenue growth guidance to 8%-9% and adjusted EPS guidance to $4.30-$4.40, but reduced adjusted free cash flow guidance to $140-$160 million. A $95.4 million discrete tax benefit materially boosted GAAP net income, while adjusted operating margin improved to 23.2% from 21.9%.","market":"sg","thumbnail":"https://resource.tradingkey.com/cdn/images/article/news/stock10.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cdn/images/article/news/stock10.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/earnings/262077133-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","FQAL","DSMC","BK4588","LGCF","TPFC","LU2065169927.USD","CALF","QUAL","SCOW","SYLD","DFNV","PKW","QLTY","ABFL","LU2065171311.SGD","ABLS","COWG","BK4585","COWZ","BK4082","SPHQ","NQLT","QFRD","MOTG","DIVB","CAFG","ICOW","MCOW","ABLG","SFLO","LIVN","LCOW","LU2065170008.USD","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657548533","title":"LivaNova Q2 FY26 GAAP Diluted EPS Rises to $1.93; Revenue Increases 10.8% Year over Year to $390.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657548533","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657548533?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:13","pubTimestamp":1785924796,"startTime":"0","endTime":"0","summary":"LivaNova Q2 FY26 GAAP diluted EPS rises to $1.93; revenue increases 10.8% year over year to $390.6 millionLivaNova posted Q2 revenue of $390.6 million, up 10.8% from a year earlier; U.S. GAAP diluted ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDLyk5Bh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0061474960.USD","LU0528227936.USD","LU1670628061.USD","LU2764263203.CNY","LU0122379950.USD","LU1923622291.USD","LU0882574055.USD","IE00BQXX3C00.GBP","LU0114720955.EUR","LU2092937221.SGD","IE00B4R5TH58.HKD","LU1989771016.USD","LU0234572021.USD","LU1623119135.USD","GB00BDT5M118.USD","HRTS","FMED","LU0316494557.USD","LU1854103824.USD","IE00BKPKM429.USD","TMED","LU1815333072.USD","LU2298321311.HKD","IE00B19Z9505.USD","LU0208291251.USD","LU2357305700.SGD","BK4535","LIVN","LU0640476718.USD","IE0034235188.USD","LU1720051017.SGD","LU2125909247.SGD","GNMX","LU2112291526.USD","LFSC","TMO","LU2764262908.HKD","LU0070302665.USD","LU2211815571.USD","LU1153585028.USD","LU1988902786.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","BK4534","LU0011850046.USD","LU2065169927.USD","LU2125909593.SGD","LU0957791311.USD","LU2764263039.SGD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657654837","title":"UK's LivaNova Q2 Revenue Beats Estimates; Lifts 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2657654837","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657654837?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:11","pubTimestamp":1785924675,"startTime":"0","endTime":"0","summary":"UK's LivaNova Q2 revenue beats estimates; lifts 2026 outlookOverviewUK medical technology firm's Q2 revenue grew 10.8%, beating analyst expectationsAdjusted EPS for Q2 beat analyst expectationsCompany","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4420EB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0096362180.USD","LU2468319806.SGD","LU2125909916.SGD","IE00BJT1NW94.SGD","CMI","LU0061474960.USD","LU0124676726.USD","LFSC","LU1815333072.USD","BK4585","IE0002141913.USD","IE00B1BXHZ80.USD","TMO","LU1169589451.USD","LIVN","IE00BKPKM429.USD","LU0342679015.USD","FMED","HRTS","BK4082","BK4581","GNMX","CLPT","LU0114720955.EUR","LU0345770993.USD","LU1559883803.SGD","LU0057025933.USD","LU0266013472.USD","LU2360108059.USD","IE00B4R5TH58.HKD","LU1064131342.USD","IE00B19Z8X17.USD","LU0203345920.USD","LU0320765489.SGD","IE0034235188.USD","LU2041044095.USD","IE00BQXX3F31.USD","TMED","LU1815336091.USD","IE000M9KFDE8.USD","LU2720916845.USD","MADE","LU2211815571.USD","LU2463526074.USD","LU0528227936.USD","LU0566484027.USD","ITGR","LU1791710400.SGD","LU1803068623.USD","LU0203347892.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657751001","title":"LivaNova Says Cardiopulmonary President Stefano Folli Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2657751001","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657751001?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:07","pubTimestamp":1785924478,"startTime":"0","endTime":"0","summary":"LivaNova says Cardiopulmonary President Stefano Folli files initial beneficial ownership statementLivaNova filed an initial ownership report for Stefano Folli, president of cardiopulmonary, showing 6,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL57w5XY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","LFSC","LIVN","BK4082","LU2065170008.USD","LU2065171311.SGD","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657104155","title":"LivaNova Q2 Adjusted EPS USD 1.26 Vs. IBES Estimate USD 1.1","url":"https://stock-news.laohu8.com/highlight/detail?id=2657104155","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657104155?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:01","pubTimestamp":1785924061,"startTime":"0","endTime":"0","summary":"BRIEF-LivaNova Q2 Adjusted EPS USD 1.26 Vs. IBES Estimate USD 1.1Aug 05  - LivaNova Q2 EPS USD 1.93.Q2 revenue USD 390.6 million vs. IBES estimate USD 380.8 millionoutlook FY adjusted EPS USD 4.3-4.4 vs. IBES estimate USD 4.25outlook FY revenue growth 8-9%outlook FY adjusted free cash flow USD 140-160 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLX8HZ676:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","LU2065170008.USD","LU2065169927.USD","BK4082","LFSC","LIVN","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657510969","title":"LivaNova Q2 Adj. EPS $1.26 Beats $1.10 Estimate, Sales $390.600M Beat $380.758M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657510969","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657510969?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:00","pubTimestamp":1785924054,"startTime":"0","endTime":"0","summary":"LivaNova (NASDAQ:LIVN) reported quarterly earnings of $1.26 per share which beat the analyst consensus estimate of $1.10 by 14.55 percent. This is a 20 percent increase over earnings of $1.05 per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60939804/livanova-q2-adj-eps-1-26-beats-1-10-estimate-sales-390-600m-beat-380-758m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065170008.USD","LU2065171402.SGD","LFSC","BK4082","LU2065171311.SGD","LU2065169927.USD","LIVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657881548","title":"LivaNova: Deal Expected to Support Increased Oxygenator Output over Time, Strengthening Co Ability to Satisfy Unmet Customer Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2657881548","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657881548?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:00","pubTimestamp":1785924001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLX8HZ676:9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0011850046.USD","TMO","LU0096362180.USD","GNMX","LU0070302665.USD","LU0432979614.USD","LU0528227936.USD","LU2357305700.SGD","BK4581","LU1291159041.SGD","LU1023059063.AUD","LU2298321311.HKD","LU1988902786.USD","IE0002141913.USD","LU1712237335.SGD","HRTS","IE00B19Z9505.USD","LU0114720955.EUR","IE00B19Z8X17.USD","LU2360108059.USD","BK4533","LU1153585028.USD","LU1923621640.USD","LU0557290698.USD","LU1791710582.SGD","TMED","LU1633808545.USD","IE00B1BXHZ80.USD","LU1803068623.USD","LU2125909759.SGD","LU2468319806.SGD","LU1983299246.USD","LU0316494557.USD","LU2764262908.HKD","LU2211815571.USD","LU2089984988.USD","LU2125910336.SGD","LU2065169927.USD","LU1670628061.USD","LU0208291251.USD","LU0345770308.USD","FMED","LU1548497426.USD","LU0342679015.USD","LU2264538146.SGD","LFSC","LIVN","IE00B19Z8W00.USD","LU1064131342.USD","LU2211814178.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657510990","title":"LivaNova Outlook FY Revenue Growth 8-9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657510990","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657510990?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:00","pubTimestamp":1785924001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLX8HZ676:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065171402.SGD","LFSC","LIVN","BK4082","LU2065170008.USD","LU2065171311.SGD","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657510191","title":"LivaNova Outlook FY Adjusted Free Cash Flow USD 140-160 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657510191","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657510191?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:00","pubTimestamp":1785924001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLX8HZ676:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","LFSC","LU2065170008.USD","LU2065171311.SGD","LIVN","LU2065171402.SGD","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657510022","title":"LivaNova - Enters Long-Term Agreement with Thermo Fisher Scientific for Oxygenator Component Supply","url":"https://stock-news.laohu8.com/highlight/detail?id=2657510022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657510022?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:00","pubTimestamp":1785924001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLX8HZ676:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1803068623.USD","LU1989771016.USD","LU1720051017.SGD","LFSC","LU2468319806.SGD","LU1064131342.USD","LU2764262908.HKD","LU0345770993.USD","LU1720051108.HKD","LU1988902786.USD","LU2065170008.USD","IE00B1BXHZ80.USD","TMO","BK4082","LU2264538146.SGD","BK4533","LU1854103824.USD","LU0061474960.USD","IE00BQXX3D17.EUR","TMED","LU1923622614.USD","LU2543165471.USD","LU0528227936.USD","BK4585","LU2089984988.USD","LU1712237335.SGD","LU1057294990.SGD","LU1153585028.USD","LU1291159041.SGD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LIVN","LU2433249047.HKD","LU1854104046.USD","LU1623119135.USD","LU0011850046.USD","GNMX","LU1983299246.USD","HRTS","LU2125909916.SGD","LU1023059063.AUD","IE00B2B36J28.USD","LU0823416689.USD","FMED","LU0882574055.USD","LU1633808545.USD","LU2360108059.USD","LU2764263039.SGD","LU2063271972.USD","IE0034235188.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657013510","title":"LivaNova Plc: Announce Agreement with Thermo Fisher Scientific","url":"https://stock-news.laohu8.com/highlight/detail?id=2657013510","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657013510?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:00","pubTimestamp":1785924001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLX8HZ676:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1854103824.USD","LU2125909247.SGD","LIVN","LU0070302665.USD","HRTS","IE00BQXX3C00.GBP","IE0002141913.USD","IE00BJJMRZ35.SGD","LU1988902786.USD","LU0208291251.USD","LU0234572021.USD","FMED","LU2764263039.SGD","LU0011850046.USD","LU2092937221.SGD","BK4534","LU0957791311.USD","IE0034235188.USD","LU1623119135.USD","LU1670628061.USD","LU1923622291.USD","LU1720051017.SGD","LU0640476718.USD","LU0061474960.USD","LU1815333072.USD","TMO","LFSC","IE00B4R5TH58.HKD","IE00BKPKM429.USD","LU0882574055.USD","IE00B19Z9505.USD","LU2125909593.SGD","BK4535","LU2089984988.USD","LU2764262908.HKD","LU2065169927.USD","LU2211815571.USD","LU2764263203.CNY","LU2298321311.HKD","LU2357305700.SGD","LU0316494557.USD","LU2112291526.USD","GNMX","LU0122379950.USD","LU0528227936.USD","LU0114720955.EUR","LU1153585028.USD","GB00BDT5M118.USD","TMED","LU1989771016.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657510573","title":"Press Release: LivaNova Reports Second-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2657510573","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657510573?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:00","pubTimestamp":1785924000,"startTime":"0","endTime":"0","summary":"-- Delivered double-digit reported revenue growth of 10.8%, with constant-currency revenue growth of 9.8%-- Raised full-year 2026 revenue and adjusted diluted earnings per share guidance-- Entered into a long-term agreement with Thermo Fisher Scientific to strengthen oxygenator component supply to expand manufacturing output and satisfy unmet demandGLOUCESTER, England----August 05, 2026--LivaNova PLC , a market-leading medical technology company, today reported results for the second quarter ended June 30, 2026 and raised full-year 2026 guidance.Financial Summary and Highlights--  Second-quarter revenue of $390.6 million increased 10.8% on a reported. basis and 9.8% on a constant-currency basis as compared to the prior-year. --  Second-quarter U.S. GAAP diluted earnings per share of $1.93 and. --  Second-quarter net cash provided by operating activities of $66.6. million and adjusted free cash flow of $45.5 million. --  Raised full-year 2026 revenue growth range by 100 basis points to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOTE","03160","DECU","BK4585","LFSC","TM","FEBU","BK4082","BK4588","BK4099","PMDE","LU2065171311.SGD","LU2065171402.SGD","BK4604","GXDW","RGLO","VGFPF","LU2065169927.USD","BK4555","LIVN","JOYT","LU2065170008.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657451663","title":"Travere Therapeutics, Inc. : Jefferies Raises Target Price to $64 from $54","url":"https://stock-news.laohu8.com/highlight/detail?id=2657451663","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657451663?lang=en_us&edition=fundamental","pubTime":"2026-08-05 15:16","pubTimestamp":1785914203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nFWN442137:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TVTX","LFSC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":199,"code":"91000000","status":"200"}]}}